DI-BOC-ALPHA-METHYL-DL-ORNITHINE
|
- $535 - $1952
- Product name: DI-BOC-ALPHA-METHYL-DL-ORNITHINE
- CAS: 1219378-96-7
- MF: C16H30N2O6
- MW: 346.42
- EINECS:
- MDL Number:MFCD04974549
- Synonyms:DI-BOC-ALPHA-METHYL-DL-ORNITHINE;2,5-bis({[(tert-butoxy)carbonyl]amino})-2-methylpentanoic acid;Ornithine, N2,N5-bis[(1,1-dimethylethoxy)carbonyl]-2-methyl-
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 100mg
- 500mg
- ManufacturerAK Scientific
- Product number1387AD
- Product descriptionDi-Boc-alpha-methyl-DL-ornithine
- Packaging100mg
- Price$772
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAAA0004259
- Product descriptionDI-BOC-ALPHA-METHYL-DL-ORNITHINE 95.00%
- Packaging100MG
- Price$907.2
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number041607
- Product descriptionDi-Boc-alpha-methyl-DL-ornithine
- Packaging100mg
- Price$535
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number041607
- Product descriptionDi-Boc-alpha-methyl-DL-ornithine
- Packaging500mg
- Price$1952
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 1387AD | Di-Boc-alpha-methyl-DL-ornithine | 100mg | $772 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | AAA0004259 | DI-BOC-ALPHA-METHYL-DL-ORNITHINE 95.00% | 100MG | $907.2 | 2021-12-16 | Buy |
| Matrix Scientific | 041607 | Di-Boc-alpha-methyl-DL-ornithine | 100mg | $535 | 2021-12-16 | Buy |
| Matrix Scientific | 041607 | Di-Boc-alpha-methyl-DL-ornithine | 500mg | $1952 | 2021-12-16 | Buy |
Properties
Boiling point :509.2±45.0 °C(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.00±0.41(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.00±0.41(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|